Advancing bRo5 Chemical Matter to the Clinic and Exploring Novel Kinase Inhibitors
Thursday, June 12 at 11am ET
Learn about the creation of novel 'bi-steric inhibitors' of mTORC1 and RAS(ON) G12D-Selective inhibitors and their journey into clinical trials, as well as innovative kinase inhibitors developed through the combination of medicinal chemistry and structural biology.